BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23097114)

  • 1. Tissue culture correlational study of genetic cholangiopathy of autosomal recessive polycystic kidney disease.
    Nakanuma Y; Sato Y; Harada K
    Methods Mol Biol; 2013; 945():303-18. PubMed ID: 23097114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix proteins of basement membrane of intrahepatic bile ducts are degraded in congenital hepatic fibrosis and Caroli's disease.
    Yasoshima M; Sato Y; Furubo S; Kizawa K; Sanzen T; Ozaki S; Harada K; Nakanuma Y
    J Pathol; 2009 Feb; 217(3):442-51. PubMed ID: 19025978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in the etiopathogenesis of pediatric biliary disease, particularly Caroli's disease with congenital hepatic fibrosis and biliary atresia.
    Nakanuma Y; Harada K; Sato Y; Ikeda H
    Histol Histopathol; 2010 Feb; 25(2):223-35. PubMed ID: 20017109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis.
    Sanzen T; Harada K; Yasoshima M; Kawamura Y; Ishibashi M; Nakanuma Y
    Am J Pathol; 2001 May; 158(5):1605-12. PubMed ID: 11337358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib.
    Sato Y; Harada K; Furubo S; Kizawa K; Sanzen T; Yasoshima M; Ozaki S; Isse K; Sasaki M; Nakanuma Y
    Am J Pathol; 2006 Oct; 169(4):1238-50. PubMed ID: 17003482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease.
    Sato Y; Harada K; Kizawa K; Sanzen T; Furubo S; Yasoshima M; Ozaki S; Ishibashi M; Nakanuma Y
    Am J Pathol; 2005 Jan; 166(1):49-60. PubMed ID: 15631999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse model for cystic biliary dysgenesis in autosomal recessive polycystic kidney disease (ARPKD).
    Moser M; Matthiesen S; Kirfel J; Schorle H; Bergmann C; Senderek J; Rudnik-Schöneborn S; Zerres K; Buettner R
    Hepatology; 2005 May; 41(5):1113-21. PubMed ID: 15830394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease.
    Togawa H; Nakanishi K; Mukaiyama H; Hama T; Shima Y; Sako M; Miyajima M; Nozu K; Nishii K; Nagao S; Takahashi H; Iijima K; Yoshikawa N
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F511-20. PubMed ID: 21084407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat.
    Masyuk TV; Huang BQ; Ward CJ; Masyuk AI; Yuan D; Splinter PL; Punyashthiti R; Ritman EL; Torres VE; Harris PC; LaRusso NF
    Gastroenterology; 2003 Nov; 125(5):1303-10. PubMed ID: 14598246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.
    Banales JM; Masyuk TV; Bogert PS; Huang BQ; Gradilone SA; Lee SO; Stroope AJ; Masyuk AI; Medina JF; LaRusso NF
    Am J Pathol; 2008 Dec; 173(6):1637-46. PubMed ID: 18988797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
    Masyuk TV; Masyuk AI; Torres VE; Harris PC; Larusso NF
    Gastroenterology; 2007 Mar; 132(3):1104-16. PubMed ID: 17383431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease.
    Masyuk TV; Huang BQ; Masyuk AI; Ritman EL; Torres VE; Wang X; Harris PC; Larusso NF
    Am J Pathol; 2004 Nov; 165(5):1719-30. PubMed ID: 15509540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease.
    Muff MA; Masyuk TV; Stroope AJ; Huang BQ; Splinter PL; Lee SO; Larusso NF
    Lab Invest; 2006 Sep; 86(9):940-50. PubMed ID: 16783394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat.
    Sato Y; Harada K; Ozaki S; Furubo S; Kizawa K; Sanzen T; Yasoshima M; Ikeda H; Sasaki M; Nakanuma Y
    Am J Pathol; 2007 Dec; 171(6):1859-71. PubMed ID: 18055542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD.
    Gradilone SA; Masyuk TV; Huang BQ; Banales JM; Lehmann GL; Radtke BN; Stroope A; Masyuk AI; Splinter PL; LaRusso NF
    Gastroenterology; 2010 Jul; 139(1):304-14.e2. PubMed ID: 20399209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease.
    Goto M; Hoxha N; Osman R; Wen J; Wells RG; Dell KM
    J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):639-44. PubMed ID: 20400910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial evaluation of hepatic T1 relaxation time as an imaging marker of liver disease associated with autosomal recessive polycystic kidney disease (ARPKD).
    Gao Y; Erokwu BO; DeSantis DA; Croniger CM; Schur RM; Lu L; Mariappuram J; Dell KM; Flask CA
    NMR Biomed; 2016 Jan; 29(1):84-9. PubMed ID: 26608869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD.
    Vijayakumar S; Dang S; Marinkovich MP; Lazarova Z; Yoder B; Torres VE; Wallace DP
    Am J Physiol Renal Physiol; 2014 Mar; 306(6):F640-54. PubMed ID: 24370592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.
    Yoshihara D; Kugita M; Sasaki M; Horie S; Nakanishi K; Abe T; Aukema HM; Yamaguchi T; Nagao S
    PLoS One; 2013; 8(12):e81480. PubMed ID: 24324698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease.
    Lee SO; Masyuk T; Splinter P; Banales JM; Masyuk A; Stroope A; Larusso N
    J Clin Invest; 2008 Nov; 118(11):3714-24. PubMed ID: 18949056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.